
2025 US Pharma Manufacturing Landscape
The 2025 US pharma manufacturing landscape is characterized by significant investments, evolving regulatory frameworks, and a growing focus on AI-driven innovation. While the US remains the world’s largest pharmaceutical market, it’s also heavily reliant on global supply